Mohammad Algahtani

1.0k total citations
48 papers, 668 citations indexed

About

Mohammad Algahtani is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mohammad Algahtani has authored 48 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Mohammad Algahtani's work include Bioactive Compounds and Antitumor Agents (4 papers), Cancer Mechanisms and Therapy (4 papers) and Electrochemical sensors and biosensors (3 papers). Mohammad Algahtani is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Cancer Mechanisms and Therapy (4 papers) and Electrochemical sensors and biosensors (3 papers). Mohammad Algahtani collaborates with scholars based in Saudi Arabia, Egypt and India. Mohammad Algahtani's co-authors include Khalid Alhazzani, Ahmed Z. Alanazi, Abdulrahman Theyab, Ali M. Alaseem, Mohamed M. El‐Wekil, Ashraf M. Mahmoud, Mater H. Mahnashi, Khalaf F. Alsharif, Ahmed Nadeem and Sheikh F. Ahmad and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Mohammad Algahtani

47 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Algahtani Saudi Arabia 16 219 96 84 72 68 48 668
Da Yeon Lee South Korea 20 573 2.6× 67 0.7× 108 1.3× 93 1.3× 58 0.9× 41 1.1k
Magdalena Kusaczuk Poland 12 295 1.3× 46 0.5× 59 0.7× 59 0.8× 61 0.9× 27 712
Peilin Yu China 19 376 1.7× 48 0.5× 93 1.1× 71 1.0× 40 0.6× 48 1.1k
С. В. Луценко Russia 13 327 1.5× 44 0.5× 82 1.0× 112 1.6× 63 0.9× 50 836
Safia Habib India 20 353 1.6× 133 1.4× 47 0.6× 62 0.9× 54 0.8× 64 1.1k
Huanhuan Pang China 20 630 2.9× 86 0.9× 67 0.8× 109 1.5× 112 1.6× 37 1.2k
Keke Jia China 12 379 1.7× 61 0.6× 112 1.3× 73 1.0× 42 0.6× 27 1.0k
An Zhu China 20 379 1.7× 49 0.5× 111 1.3× 122 1.7× 80 1.2× 69 985
Fengyi Zhao China 19 336 1.5× 45 0.5× 63 0.8× 40 0.6× 109 1.6× 49 1.0k

Countries citing papers authored by Mohammad Algahtani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Algahtani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Algahtani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Algahtani more than expected).

Fields of papers citing papers by Mohammad Algahtani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Algahtani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Algahtani. The network helps show where Mohammad Algahtani may publish in the future.

Co-authorship network of co-authors of Mohammad Algahtani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Algahtani. A scholar is included among the top collaborators of Mohammad Algahtani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Algahtani. Mohammad Algahtani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alanazi, Ahmed Z., Mohammad Algahtani, Faisal Alotaibi, et al.. (2025). Investigation of The Hepatoprotective Potential of Liposomal Resveratrol as Polyphenols Against Liver Damage in Streptozotocin Diabetic Rat Model. International Journal of Medical Sciences. 22(13). 3380–3392. 1 indexed citations
2.
Alhazzani, Khalid, Mohammad Algahtani, Khaldoon Aljerian, et al.. (2024). Integrating Metabolomics, Histopathology, and Cardiac Marker Analysis to Assess Valsartan’s Efficacy in Mitigating Dasatinib-Induced Cardiac Toxicity in Sprague-Dawley Rats. Drug Design Development and Therapy. Volume 18. 5641–5654. 1 indexed citations
3.
Algahtani, Mohammad, et al.. (2023). Advancing nanomedicine production via green thermal supercritical processing: Laboratory measurement and thermodynamic modeling. Journal of Molecular Liquids. 383. 122042–122042. 9 indexed citations
4.
Algahtani, Mohammad, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.. (2023). Inhibition of ITK Signaling Causes Amelioration in Sepsis-Associated Neuroinflammation and Depression-like State in Mice. International Journal of Molecular Sciences. 24(9). 8101–8101. 7 indexed citations
5.
Alqinyah, Mohammed, Mohammad Algahtani, Amira M. Badr, et al.. (2023). Targeting Store-Operated Calcium Entry Regulates the Inflammation-Induced Proliferation and Migration of Breast Cancer Cells. Biomedicines. 11(6). 1637–1637. 4 indexed citations
6.
Al‐Harbi, Naif O., Sheikh F. Ahmad, Sabry M. Attia, et al.. (2023). Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE. Biomedicines. 11(9). 2502–2502. 7 indexed citations
7.
Alanazi, Ahmed Z., Khalid Alhazzani, Khaldoon Aljerian, et al.. (2023). The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity. Pharmaceuticals. 16(7). 921–921. 6 indexed citations
8.
Alaseem, Ali M., Khalid Alhazzani, Ahmed Z. Alanazi, et al.. (2023). Preclinical In Vitro Investigation of MDM2 Inhibition in Combination with Antiangiogenic Therapy for Breast Cancer Treatment. Scientia Pharmaceutica. 91(1). 12–12. 2 indexed citations
9.
10.
Alhazzani, Khalid, Khaldoon Aljerian, Khaled Alhosaini, et al.. (2023). Hydroxychloroquine ameliorates dasatinib-induced liver injury via decrease in hepatic lymphocytes infiltration. Human & Experimental Toxicology. 42. 3530206732–3530206732. 4 indexed citations
11.
12.
Singla, M., Saurabh Gupta, Omji Porwal, et al.. (2023). Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route. Frontiers in Pharmacology. 14. 1218625–1218625. 15 indexed citations
13.
Eid, Refaat A., Mohamed A. Soltan, Muhammad Alaa Eldeen, et al.. (2022). Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. International Journal of Molecular Sciences. 23(22). 14102–14102. 14 indexed citations
14.
Beg, Sarwar, Ankit Kumar Malik, Mohammad Javed Ansari, et al.. (2022). Systematic Development of Solid Lipid Nanoparticles of Abiraterone Acetate with Improved Oral Bioavailability and Anticancer Activity for Prostate Carcinoma Treatment. ACS Omega. 7(20). 16968–16979. 30 indexed citations
15.
Alhazzani, Khalid, et al.. (2022). Evaluation of antitumor effects of VEGFR-2 inhibitor F16 in a colorectal xenograft model. Biotechnology Letters. 44(5-6). 787–801. 1 indexed citations
16.
Alzahrani, Khalid J., Abdulrahman Theyab, Osama M. Al‐Amer, et al.. (2022). Apigenin protects from hepatorenal damage caused by lead acetate in rats. Journal of Biochemical and Molecular Toxicology. 37(3). e23275–e23275. 9 indexed citations
17.
Alqinyah, Mohammed, et al.. (2022). Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response. Saudi Pharmaceutical Journal. 31(2). 245–254. 8 indexed citations
18.
Al‐Mazroua, Haneen A., Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.. (2022). CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery. Molecular Immunology. 144. 127–137. 27 indexed citations
19.
Al‐Amer, Osama M., Atif Abdulwahab A. Oyouni, Mohammed Ali Alshehri, et al.. (2021). Association of SNPs within TMPRSS6 and BMP2 genes with iron deficiency status in Saudi Arabia. PLoS ONE. 16(11). e0257895–e0257895. 5 indexed citations
20.
Mahmoud, Ashraf M., Mater H. Mahnashi, Khalid Alhazzani, et al.. (2021). Nitrogen doped graphene quantum dots based on host guest interaction for selective dual readout of dopamine. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 252. 119516–119516. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Da Yeon Lee Breakdown of academic impact, for papers by Magdalena Kusaczuk Breakdown of academic impact, for papers by Peilin Yu Breakdown of academic impact, for papers by С. В. Луценко Breakdown of academic impact, for papers by Safia Habib Breakdown of academic impact, for papers by Huanhuan Pang Breakdown of academic impact, for papers by Keke Jia Breakdown of academic impact, for papers by An Zhu Breakdown of academic impact, for papers by Fengyi Zhao
Rankless by CCL
2026